Erik C. Yusko
Erik C. Yusko
Adaptive Biotechnologies
Verified email at
Cited by
Cited by
Controlling protein translocation through nanopores with bio-inspired fluid walls
EC Yusko, JM Johnson, S Majd, P Prangkio, RC Rollings, J Li, J Yang, ...
Nature nanotechnology 6 (4), 253-260, 2011
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeHybrid Capture–Based NGS and Response to Anti–PD-1
DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ...
Cancer immunology research 4 (11), 959-967, 2016
Applications of biological pores in nanomedicine, sensing, and nanoelectronics
S Majd, EC Yusko, YN Billeh, MX Macrae, J Yang, M Mayer
Current opinion in biotechnology 21 (4), 439-476, 2010
Real-time shape approximation and fingerprinting of single proteins using a nanopore
EC Yusko, BR Bruhn, OM Eggenberger, J Houghtaling, RC Rollings, ...
Nature nanotechnology 12 (4), 360-367, 2017
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
JM Wrangle, V Velcheti, MR Patel, E Garrett-Mayer, EG Hill, JG Ravenel, ...
The Lancet Oncology 19 (5), 694-704, 2018
Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 …
SJ Dovedi, EJ Cheadle, AL Popple, E Poon, M Morrow, R Stewart, ...
Clinical Cancer Research 23 (18), 5514-5526, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis
A Snyder, T Nathanson, SA Funt, A Ahuja, J Buros Novik, MD Hellmann, ...
PLoS medicine 14 (5), e1002309, 2017
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma
AC Hopkins, M Yarchoan, JN Durham, EC Yusko, JA Rytlewski, ...
JCI insight 3 (13), 2018
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
SK Subudhi, A Aparicio, J Gao, AJ Zurita, JC Araujo, CJ Logothetis, ...
Proceedings of the National Academy of Sciences 113 (42), 11919-11924, 2016
Electroosmotic flow can generate ion current rectification in nano-and micropores
EC Yusko, R An, M Mayer
Acs Nano 4 (1), 477-487, 2010
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical RecurrenceTCR Intratumor …
A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko, CJ Wu, R Emerson, ...
Cancer discovery 7 (10), 1088-1097, 2017
Concurrent PD-1 blockade negates the effects of OX40 agonist antibody in combination immunotherapy through inducing T-cell apoptosis
RK Shrimali, S Ahmad, V Verma, P Zeng, S Ananth, P Gaur, RM Gittelman, ...
Cancer immunology research 5 (9), 755-766, 2017
Ibrutinib therapy increases T cell repertoire diversity in patients with chronic lymphocytic leukemia
Q Yin, M Sivina, H Robins, E Yusko, M Vignali, S O’Brien, MJ Keating, ...
The Journal of Immunology 198 (4), 1740-1747, 2017
Comprehensive T cell repertoire characterization of non-small cell lung cancer
A Reuben, J Zhang, SH Chiou, RM Gittelman, J Li, WC Lee, J Fujimoto, ...
Nature communications 11 (1), 1-13, 2020
Single-particle characterization of Aβ oligomers in solution
EC Yusko, P Prangkio, D Sept, RC Rollings, J Li, M Mayer
ACS nano 6 (7), 5909-5919, 2012
Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity
P Prangkio, EC Yusko, D Sept, J Yang, M Mayer
Public Library of Science 7 (10), e47261, 2012
Force is a signal that cells cannot ignore
EC Yusko, CL Asbury
Molecular biology of the cell 25 (23), 3717-3725, 2014
Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes
HR Seay, E Yusko, SJ Rothweiler, L Zhang, AL Posgai, ...
JCI insight 1 (20), 2016
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma
D Agdashian, M ElGindi, C Xie, M Sandhu, D Pratt, DE Kleiner, WD Figg, ...
Cancer Immunology, Immunotherapy 68 (4), 599-608, 2019
TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC VaccinationTCR Usage in Glioblastoma Patients before and after DC Vaccination
MS Hsu, S Sedighim, T Wang, JP Antonios, RG Everson, AM Tucker, L Du, ...
Cancer immunology research 4 (5), 412-418, 2016
The system can't perform the operation now. Try again later.
Articles 1–20